Human TFAP2B adenoviral particles

TFAP2B (transcription factor AP-2β) is a member of the AP-2 family of transcription factors that plays a key role in embryonic development, cell differentiation, and tissue homeostasis. The gene encodes a protein that binds to specific DNA sequences and regulates the expression of target genes involved in neural crest development, adipogenesis, and kidney morphogenesis. Mutations in the TFAP2B gene are associated with genetic disorders such as Char syndrome, which is characterized by patent ductus arteriosus, facial dysmorphism, and hand abnormalities. The protein's ability to regulate gene expression has made it of interest in research areas such as developmental biology, metabolic diseases, and cancer. Human TFAP2B Adenoviral Particles are genetically engineered viral vectors designed to deliver the TFAP2B gene to target cells for overexpression studies. These particles utilize a replication-defective adenoviral backbone, ensuring efficient transduction of a variety of cell types, including primary cells and difficult-to-transfect cells. The high transduction efficiency and stable transgene expression of this adenoviral system make it ideal for functional analysis, gene therapy studies, and mechanistic studies. These particles are produced under strict quality control to ensure high titer and purity and to minimize off-target effects. Researchers can use TFAP2B adenoviral particles to explore gene regulation, cell differentiation, and disease modeling.